THE first US trial over claims that discontinued heartburn drug Zantac causes cancer is now expected to take place in California state court in Nov, reported Reuters.
Plaintiffs in the litigation claim that Zantac causes nine forms of cancer, including colorectal, breast and bladder cancer.
Thousands of lawsuits over Zantac have been filed in California against GSK, Sanofi, Pfizer and Boehringer Ingelheim, which all sold the drug at various times.
In 2019, some manufacturers halted Zantac sales over concerns that its active ingredient, ranitidine, degraded over time to form a chemical called NDMA (N-Nitrosodimethylamine).
While NDMA can be present in low levels in food and water, research has found it causes cancer in larger amounts, Reuters reported.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Jul 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Jul 23
Warning: Undefined variable $o_shortcode_atts in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1263
Warning: Undefined variable $output in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1266
